EUVIMEDEUVIMED entdecken
Open Access

Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology

Mamatha Damodarasamy, Gustavo J Hernandez, Richard S Johnson, C Dirk Keene, Caitlin S Latimer, Michael J MacCoss, William A Banks, Michelle A Erickson, May J Reed iD

Journal of Alzheimer’s Disease · 2026-05 · 111 (2) · 530-536

DOI: 10.1177/13872877261433167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 20.03.2026. Verfasst von Mamatha Damodarasamy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Collagen Type IV, Basement Membrane, Microvessels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Nancy and the Buster Alvord Endowed Chair in Neuropathology, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid-β (Aβ) can deposit in or near the microvascular basement membrane (BM) in Alzheimer's disease (AD). We examined the effect of the Aβ binding antibody, lecanemab, on BM collagen IV (Col-IV) using viable brain microvessels (MV) isolated from human postmortem brain tissue with high AD neuropathologic change (ADNC=3, 16 females (mean 86 years), 11 males (mean 81 years)). MVs were exposed to lecanemab or isotype for 4 days and examined for Col-IV related outcomes: western blotting, capillary electrophoresis, RT-PCR, and degraded Col-IV. We find a subset of MV from some donors demonstrate Col-IV changes that could cause microvascular injury when exposed to lecanemab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCollagen Type IVBasement MembraneMicrovesselsBrainHumansFemaleMaleAged, 80 and overAged

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid-betabasement membranecollagen IVextracellular matrixlecanemabmicrovasculature

Substanzen

Collagen Type IV

Autor:innen und Institutionen

  • Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA, USA.
  • Veterans Affairs Puget Sound Health Care System, Geriatric Research Education and Clinical Center, Seattle, WA, USA.
  • Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Department of Laboratory Medicine and Pathology, Division of Neuropathology, University of Washington, Seattle, WA, USA.

ORCID-Profile: May J Reed

Förderung

  • NIA NIH HHS
  • Nancy and the Buster Alvord Endowed Chair in Neuropathology
  • NIH

Zitieren

APA

Damodarasamy, M., Hernandez, G. J., Johnson, R. S., Keene, C. D., Latimer, C. S., MacCoss, M. J., Banks, W. A., Erickson, M. A., & Reed, M. J. (2026). Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology. Journal of Alzheimer’s Disease, 111(2), 530-536. https://doi.org/10.1177/13872877261433167

Vancouver

Damodarasamy M, Hernandez GJ, Johnson RS, Keene CD, Latimer CS, MacCoss MJ, et al. Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology. Journal of Alzheimer’s Disease. 2026;111(2):530-536. doi:10.1177/13872877261433167

BibTeX
@article{Damodarasamy2026,
  author = {Damodarasamy, Mamatha and Hernandez, Gustavo J and Johnson, Richard S and Keene, C Dirk and Latimer, Caitlin S and MacCoss, Michael J and Banks, William A and Erickson, Michelle A and Reed, May J},
  title = {Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  volume = {111},
  number = {2},
  pages = {530--536},
  doi = {10.1177/13872877261433167}
}
Kostenlos starten →